During the WSJ Leadership Institute CEO Summit in London last week, Johnson & Johnson Chairman and CEO Joaquin Duato reflected on the pharmaceutical company\u2019s projections on the future of cancer treatment.<\/p>\n
In the next 10 years, the goal is to “try to eliminate cancer,” Duato shared.<\/p>\n
NEW CANCER VACCINE DELIVERS STUNNING RESULT AGAINST ONE OF THE DEADLIEST SKIN CANCERS<\/a><\/p>\n “That\u2019s a high goal, and we are already making significant progress in certain cancers<\/a>,” he said.<\/p>\n Duato used multiple myeloma as an example, noting that the life expectancy is currently 10 years, when it was previously “only single years.”<\/p>\n Joaquin Duato, chairman and CEO of Johnson and Johnson, speaks at the Punchbowl News Conference at Union Station on March 10, 2026, in Washington, DC. (Heather Diehl\/Getty Images)<\/p>\n “We have treatments now that utilize your own immune system to attack the cancer<\/a>,” he said at the summit. “For patients who were already going into hospice, so they didn\u2019t have any other alternative, they are [at] more than five years, with a single administration, in remission. That [is] spectacular.”<\/p>\n CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER<\/a><\/p>\n “When patients see that, they cannot believe that because they have been coming to the hospital every week [for] a decade, having multiple therapies.”<\/p>\n The goal is to “try to eliminate cancer” in the next 10 years, the pharmaceutical executive said. (iStock)<\/p>\n According to Duato, Johnson & Johnson is working to understand the biology of cancer growth<\/a> and to formulate new technologies to address it.<\/p>\n “It\u2019s realistic to believe that we are going to cure certain cancers, and some others we\u2019re going to turn into chronic diseases,” he predicted.<\/p>\n CLICK HERE FOR MORE HEALTH STORIES<\/a><\/p>\n “Cancer is an important thing \u2013 I cannot think about anybody who has not been touched by cancer,” he went on. “But there are many other opportunities for us to actually advance science<\/a>, to address very important social problems.”<\/p>\n Duato called out dementia as another “important problem” in need of a solution.<\/p>\n CLICK HERE TO DOWNLOAD THE FOX NEWS APP<\/a><\/p>\n He predicted that life expectancy, which has risen steadily<\/a> over the past century, will continue to increase as longevity technologies and solutions advance, improving quality of life along the way.<\/p>\n Duato commented that J&J has been optimistic about the role artificial intelligence will play in the future of healthcare, calling it a “force multiplier.”<\/p>\n Biomarkers and AI can help with the earlier diagnosis of cancer, as well as a more advanced and personalized approach to surgery, a doctor noted. (iStock)<\/p>\n Fox News senior medical analyst Dr. Marc Siegel agreed with Duato’s outlook on the future of cancer care, noting that certain cancers will turn into chronic diseases<\/a> while others will find outright cures.<\/p>\n “Advances [will be] based on the use of AI to help guide targeted treatments with expanding knowledge of cancer mutations and how to target them,” he predicted, speaking to Fox News Digital.<\/p>\n![\"joaquin](\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/06\/54748500-580b-4bb2-9a6a-e5db675a1e5f_joaquin-duato-jj-ceo.jpg\")
<\/p>\n![\"A](\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/06\/cancer-patient-chemotherapy-nurse-fox-news-001.jpeg\")
<\/p>\n![\"woman](\"https:\/\/www.newsbeep.com\/uk\/wp-content\/uploads\/2026\/06\/woman-breast-cancer-patient.jpg\")
<\/p>\n